|
Re: FXR and liver transaminase related adverse events
|
3
|
Resverlogix Corp.
|
Oct 03, 2018 02:55PM
|
|
Re: tiny volume
|
1
|
Resverlogix Corp.
|
Oct 03, 2018 09:50PM
|
|
Re: Clovis' Rubracra
|
6
|
Zenith Epigenetics
|
Oct 05, 2018 03:18AM
|
|
Interesting observation today
|
9
|
Resverlogix Corp.
|
Oct 08, 2018 06:10PM
|
|
Price and volume theory for today's trading
|
6
|
Resverlogix Corp.
|
Oct 09, 2018 04:12PM
|
|
Re: The countdown to 250
|
3
|
Resverlogix Corp.
|
Oct 10, 2018 03:43PM
|
|
Re: Must be a dilutive financing in the works...
|
7
|
Resverlogix Corp.
|
Oct 18, 2018 11:48AM
|
|
Re: So what is upcoming that can hopefully affect the price,...
|
5
|
Resverlogix Corp.
|
Oct 20, 2018 01:05PM
|
|
Re: So what is upcoming that can hopefully affect the price,...
|
2
|
Resverlogix Corp.
|
Oct 21, 2018 12:03PM
|
|
Re: How about a Naz listing to move the price?
|
5
|
Resverlogix Corp.
|
Oct 21, 2018 12:30PM
|
|
Re: BMO Current Value at 0
|
6
|
Zenith Epigenetics
|
Oct 31, 2018 12:12PM
|
|
Re: The scariest thing for a clinical trial......
|
2
|
Resverlogix Corp.
|
Oct 31, 2018 08:48PM
|
|
Re: ... unfinished business
|
5
|
Zenith Epigenetics
|
Nov 02, 2018 03:03AM
|
|
Re: AHA 2018 Resverlogix Poster #2
|
2
|
Resverlogix Corp.
|
Nov 13, 2018 03:23AM
|
|
Re: AHA 2018 Resverlogix Poster #2
|
3
|
Resverlogix Corp.
|
Nov 13, 2018 12:24PM
|
|
Re: Amarin CEO interview - New class action lawsuit
|
3
|
Resverlogix Corp.
|
Nov 14, 2018 07:55PM
|
|
Re: NEJM Editorial on REDUCE-IT
|
2
|
Resverlogix Corp.
|
Nov 16, 2018 04:18PM
|
|
Re: Why such little intrest, so close to the finis
|
8
|
Resverlogix Corp.
|
Nov 16, 2018 11:50PM
|
|
Re: Possible Zenith deal,..
|
5
|
Resverlogix Corp.
|
Nov 17, 2018 03:00PM
|
|
Re: Primary endpoint: Time vs Absolute Numbers
|
4
|
Resverlogix Corp.
|
Nov 19, 2018 01:39PM
|
